Chidamide Suppresses the Growth of Cholangiocarcinoma by Inhibiting HDAC3 and Promoting FOXO1 Acetylation

• Váldodahkkit: Yongpan Li (Dahkki), Jujia Zheng (Dahkki), Qiang Huo (Dahkki), Zhongchao Chen (Dahkki), Jun Chen (Dahkki), Xiangwei Xu (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Hindawi Limited, 2022-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Inhibitors for histone deacetylases (HDACs) have been identified as epigenetic drug targets to treat a variety of malignancies through several molecular mechanisms. The present study is aimed at investigating the mechanism underlying the possible antitumor effect of the HDAC inhibitor chidamide (CDM...